Multicentric evaluation of new commercial enzyme immunoassays for the detection of immunoglobulin M and total antibodies against hepatitis A virus

Clinical and Vaccine Immunology

Volumn 18, Issue 8, 2011, Pages 1391-1394

  Arcangeletti, M C ^a   Dussaix, E ^b   Ferraglia, F ^a   Roque Afonso, A M ^b   Graube, A ^b   Chezzi, C ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYMPTOM;

CLINICAL LABORATORY TECHNIQUES; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN M;

EID: 79961124926     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00403-10     Document Type: Article

References (18)

1. Bouvet, E. 2005. Sexual practices and transmission of HAV and HCV. Euro Surveill. 10:74.
2. Centers for Disease Control and Prevention. 2006. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommend. Rep. 55(RR-7):1-23.
3. Chodick, G., S. Ashkenazi, and Y. Lerman. 2006. The risk of hepatitis A infection among healthcare workers: a review of reported outbreaks and sero-epidemiologic studies. J. Hosp. Infect. 62:414-420.
4. FitzSimons, D., G. Hendrickx, A. Vorsters, and P. Van Damme. 2010. Hepatitis A and E: update on prevention and epidemiology. Vaccine 28:583-588.
5. Hollinger, F. B., et al. 2007. Hepatitis A and B vaccination and public health. J. Viral Hepat. 14(Suppl. 1):1-5.
6. Jacobsen, K. H., and J. S. Koopman. 2005. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int. J. Epidemiol. 34:600-609. (Pubitemid 40852576)
7. Jacobsen, K. H., and S. T. Wiersma. 2010. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 28:6653-6657.
8. Latimer, W. W., et al. 2007. Prevalence and correlates of hepatitis A among adult drug users: the significance of incarceration and race/ethnicity. Vaccine 25:7125-7131. (Pubitemid 47470096)
9. Nainan, O. V., G. Xia, G. Vaughan, and H. S. Margolis. 2006. Diagnosis of hepatitis A virus infection: a molecular approach. Clin. Microbiol. Rev. 19:63-79. (Pubitemid 43157647)
10. Nelson, K. E. 2006. Global changes in the epidemiology of hepatitis A virus infections. Clin. Infect. Dis. 42:1151-1152.
11. Nothdurft, H. D., et al. 2007. The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination. J. Travel Med. 14:181-187. (Pubitemid 46596285)
12. Reimer, J., et al. 2007. Multiple viral hepatitis in injection drug users and associated risk factors. J. Gastroenterol. Hepatol. 22:80-85. (Pubitemid 44953421)
13. Roque-Afonso, A. M., V. Mackiewicz, and E. Dussaix. 2006. Detection of immunoglobulin M antibody to hepatitis A virus in patients without acute hepatitis A: the usefulness of specific immunoglobulin G avidity. Clin. Infect. Dis. 42:887-888. (Pubitemid 43363949)
14. Shim, M., I. Khaykis, J. Park, and E. J. Bini. 2005. Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination. Hepatology 42:688-695. (Pubitemid 41233663)
15. Stene-Johansen, K., et al. 2007. Molecular epidemiological studies show that hepatitis A virus is endemic among active homosexual men in Europe. J. Med. Virol. 79:356-365. (Pubitemid 46355434)
16. Taylor, R. M., et al. 2006. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology 44:1589-1597. (Pubitemid 44953664)
17. Toovey, S. 2006. Travelling to Africa: health risks reviewed. Travel Med. Infect. Dis. 4:147-158.
18. Victor, J. C., et al. 2006. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. Am. J. Epidemiol. 163:204-210. (Pubitemid 43145746)